Hyderabad Telangana, India

Srihari Raju Kalidindi

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Srihari Raju Kalidindi: Innovator in Pharmaceutical Compositions

Introduction

Srihari Raju Kalidindi is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of SGLT2 inhibitors. With a total of 8 patents to his name, Kalidindi's work has the potential to impact therapeutic applications significantly.

Latest Patents

One of his latest patents focuses on co-crystals of SGLT2 inhibitors, detailing the processes for their preparation and the pharmaceutical compositions derived from them. This invention provides solid forms of SGLT2 inhibitors, outlines processes for their purification, and discusses their therapeutic uses. The innovative approach taken in this patent showcases Kalidindi's commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Srihari Raju Kalidindi has worked with notable companies such as Laurus Labs Private Limited and Pharmis Biofarmacêutica, Lda. His experience in these organizations has allowed him to hone his skills and contribute to significant advancements in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Venkata Sunil Kumar Indukuri and Satyanarayana Chava. Their collaborative efforts have likely played a role in the successful development of various projects and patents.

Conclusion

Srihari Raju Kalidindi stands out as an influential inventor in the pharmaceutical sector, with a focus on SGLT2 inhibitors and their applications. His contributions through patents and collaborations continue to shape the future of therapeutic innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…